Presentation The Structural Heart Disease Summit 2018 Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency Presenter: Harindra Wijeysundera June 21, 2018 REGISTER for free or LOG IN to view this content Structural Heart Presentation The Structural Heart Disease Summit 2018 Aortic Valve Up Next Presentation The Structural Heart Disease Summit 2018 Evolut R Low-Risk Presenter: Jeffrey J. Popma June 21, 2018 More slides + Presentation The Structural Heart Disease Summit 2018 The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications Presenter: Susheel K. Kodali June 21, 2018 Presentation The Structural Heart Disease Summit 2018 UK All-Comers Presenter: Neil E. Moat June 21, 2018 We Recommend
Presentation The Structural Heart Disease Summit 2018 Evolut R Low-Risk Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications Presenter: Susheel K. Kodali June 21, 2018
Presentation The Structural Heart Disease Summit 2018 UK All-Comers Presenter: Neil E. Moat June 21, 2018